Literature DB >> 21427615

Increased consumption of hospital resources due to complications: an assessment of costs in a level I trauma center.

Mariska A C de Jongh1, Eelke Bosma, Luke P H Leenen, Michael H J Verhofstad.   

Abstract

BACKGROUND: Hospital complications can pose a threat to patients, contribute to higher mortality and morbidity, and increase both the average length of hospital stay (LOS) and the use of other resources. The purpose of this study is to express the relationship between complications and the use of hospital resources in financial parameters.
METHODS: All trauma patients admitted to the surgical ward in the period 2000 to 2008 were analyzed (n = 4,377). All activities registered during admission were obtained. The integral in-hospital cost prices of each activity were divided into various product groups. Median and interquartile ranges were presented for the number of activities in the product groups, stratified by age and Injury Severity Score. The relationship between both institutional- and trauma-related complications and the number of activities in the different product groups was tested with linear regression analysis with adjustment for confounding.
RESULTS: Significant associations between trauma-related complications and LOS, therapeutic paramedical products, diagnostic radiologic products, other diagnostic products, diagnostic laboratory products, therapeutic surgical procedures, other therapeutic products, and total costs (β = 5,420; 95% confidence interval, 4,912-5,929) were found. Significant associations between institutional-related complications and LOS, therapeutic paramedical products, diagnostic radiologic products, therapeutic surgical procedures, and other therapeutic products were found. Total costs (β = 170; 95% confidence interval, -760 to 1,099) showed a nonsignificant association with institutional-related complications.
CONCLUSION: Complications increase hospital costs, and even a small reduction in the number of complications will result in a substantial hospital cost savings and a reduction in the emotional and physical burdens of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21427615     DOI: 10.1097/TA.0b013e31820e351f

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

1.  Derivation and validation of actionable quality indicators targeting reductions in complications for injury admissions.

Authors:  Abakar Idriss-Hassan; Mélanie Bérubé; Amina Belcaïd; Julien Clément; Gilles Bourgeois; Christine Rizzo; Xavier Neveu; Kahina Soltana; Jaimini Thakore; Lynne Moore
Journal:  Eur J Trauma Emerg Surg       Date:  2021-05-07       Impact factor: 3.693

2.  Incidence of post-traumatic pneumonia in poly-traumatized patients: identifying the role of traumatic brain injury and chest trauma.

Authors:  Martijn Hofman; Hagen Andruszkow; Philipp Kobbe; Martijn Poeze; Frank Hildebrand
Journal:  Eur J Trauma Emerg Surg       Date:  2019-07-03       Impact factor: 3.693

3.  Accuracy of Tissue and Sonication Fluid Sampling for the Diagnosis of Fracture-Related Infection: A Systematic Review and Critical Appraisal.

Authors:  Jolien Onsea; Melissa Depypere; Geertje Govaert; Richard Kuehl; Thomas Vandendriessche; Mario Morgenstern; Martin McNally; Andrej Trampuz; Willem-Jan Metsemakers
Journal:  J Bone Jt Infect       Date:  2018-08-10

4.  Improving length of stay on a trauma service.

Authors:  Walter L Biffl; Ning Lu; Peter R Schultz; Jiayan Wang; Matthew R Castelo; Kathryn B Schaffer
Journal:  Trauma Surg Acute Care Open       Date:  2021-08-26

Review 5.  Complication rates as a trauma care performance indicator: a systematic review.

Authors:  Lynne Moore; Henry Thomas Stelfox; Alexis F Turgeon
Journal:  Crit Care       Date:  2012-10-16       Impact factor: 9.097

6.  Complications of trauma patients admitted to the ICU in level I academic trauma centers in the United States.

Authors:  Stefania Mondello; Amy Cantrell; Domenico Italiano; Vincenzo Fodale; Patrizia Mondello; Darwin Ang
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.